Radiosensitivity of Tumor Cell Lines after Pretreatment with the EGFR Tyrosine Kinase Inhibitor ZD1839 (Iressa®)

2005 ◽  
Vol 181 (3) ◽  
pp. 197-204 ◽  
Author(s):  
Susanne Burdak-Rothkamm ◽  
Claudia E. Rübe ◽  
Tan Phu Nguyen ◽  
Daniela Ludwig ◽  
Klaus Feldmann ◽  
...  
Keyword(s):  
Tyrosine Kinase ◽  
Tumor Cell ◽  
Tyrosine Kinase Inhibitor ◽  
Cell Lines ◽  
Kinase Inhibitor ◽  
Tumor Cell Lines ◽  
Egfr Tyrosine Kinase Inhibitor ◽  
Egfr Tyrosine Kinase

Synergistic Effects of Metformin Treatment in Combination with Gefitinib, a Selective EGFR Tyrosine Kinase Inhibitor, in LKB1 Wild-type NSCLC Cell Lines

2013 ◽  
Vol 19 (13) ◽  
pp. 3508-3519 ◽  
Author(s):  
Floriana Morgillo ◽  
Ferdinando Carlo Sasso ◽  
Carminia Maria Della Corte ◽  
Donata Vitagliano ◽  
Elena D'Aiuto ◽  
...  
Keyword(s):  
Tyrosine Kinase ◽  
Tyrosine Kinase Inhibitor ◽  
Cell Lines ◽  
Kinase Inhibitor ◽  
Synergistic Effects ◽  
Nsclc Cell ◽  
Metformin Treatment ◽  
Wild Type ◽  
Egfr Tyrosine Kinase Inhibitor ◽  
Egfr Tyrosine Kinase
Sign in / Sign up

Export Citation Format

Share Document